As of 2025-07-11, the Fair Value of Bicara Therapeutics Inc (BCAX) is -9.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.92 USD, the upside of Bicara Therapeutics Inc is -196.89%.
With the market price of 9.92 USD and our fair value calculation, Bicara Therapeutics Inc (BCAX) is not a good investment. Investing in BCAX stocks now will result in a potential loss of 196.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2022-12-31 | 2023-12-31 | 2024-12-31 | - | - | 5Y Avg | |
| Net income | -51.99 | -68.00 | - | - | -59.99 | |
| YoY growth | -37.36% | -30.80% | - | - | -34.08% | |
| Market Cap (mil) | 541.04 |
| P/E | |
| Forward P/E |
| EPS | -1.92 |
| Avg earnings growth rate | -34.08% |
| TTM earnings | -104.84 |